Pharma firm gets FDA notice

23rd May 2014

Drug authority issues notices to Wockhardt’s three plants in Aurangabad and seeks explanation on poor compliance with good manufacturing practices.

Biomedical waste dumped openly, rusted drums containing glycerine — used in making injections — lying unused for months, proliferation of insects, rodent excreta which raises a stink and storage of raw material in rusted barrels.


Read full article at source

Leave a Reply

Your email address will not be published.

+ 48 = 50

« back to posts